Zydus Lifesciences shares surged 7% to an intraday high of Rs 947.95 on the BSE on Thursday after receiving final approval ...

The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...

Zydus Lifesciences added 3.33% to Rs 917.10 after the company said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture generic Dasatinib ...

Stocks like Wipro, Walchandnagar Industries, Hindustan Zinc, R Systems International, Kirloskar Industries, Zaggle Prepaid ...

IT services company TCS has collaborated with Vantage Towers, Europe’s second-largest telecom tower operator, to introduce a ...

The company launched ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients. ANVIMO will ...

Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

This collaboration is in addition to Biocon Biologics’ own insulin aspart drug product for the US, which is currently under ...

Stocks including TCS, Wipro, Dalmia Bharat, Zydus Life, LIC Housing, Hindustan Zinc, R Systems, Zaggle Prepaid, IRFC and ...

The NSE Nifty 50 ended 254.65 points or 1.15% higher at 22,337.30, while the BSE Sensex closed 740.30 points or 1.01% up at ...